MJBizDaily Newsletter

Get our daily email

More Exclusive Features

Chart: US-affiliated medical cannabis firms led fundraising on Canadian Securities Exchange in 2018

U.S.-affiliated medical cannabis companies dominated Canadian Securities Exchange (CSE) fundraising in 2018, raising nearly $2 billion through 50 equity-related deals. As of December 2018, 47% of the 124 cannabis-related companies trading on the CSE were based in the United States or had U.S. assets or interests. Cannabis-related companies in the life sciences sector – which […]

Read More

2019 could be a big year for marijuana reform in Congress

The U.S. Congress always has been slow to act, but that’s been especially true for marijuana reform, which has been a stigmatized issue for decades.

As a result, cannabis companies have been waiting and hoping for years that Congress will take action to guarantee banking access to law-abiding marijuana businesses and ease the excessive tax burden from 280E.

Read More

If these Northeast states legalize adult-use marijuana, they could generate billions of dollars in sales

The legalization of recreational marijuana appears poised to sweep across the Northeast, which could result in billions of dollars of business opportunities over the next few years in a densely populated region of the nation. “Now that there’s (retail marijuana) stores in Massachusetts, we are really starting to see the dominoes fall,” said Matt Schweich, […]

Read More

Cannabis firms in M&A hunt look beyond Canada for growth

Canadian medical cannabis companies are increasingly looking internationally for acquisitions to tap growth while consolidation in the country’s marijuana sector continues to steam ahead. Last year, 140 U.S. cannabis companies were targets of mergers and acquisitions, a substantial increase over 2017’s 86, according to data compiled by Viridian Capital Advisors and shared with Marijuana Business […]

Read More